These clinical studies underscore the difficulty in elucidating the role of leptin in the pathogenesis of CVD in CKD amongst the meshwork of other contributing factors to the CVD burden in this patient population, including nutrition, inflammation and conventional cardiovascular risk factors. This evidence concerns the gene LEP and chronic kidney disease.